[go: up one dir, main page]

DE60119514D1 - Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure - Google Patents

Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure

Info

Publication number
DE60119514D1
DE60119514D1 DE60119514T DE60119514T DE60119514D1 DE 60119514 D1 DE60119514 D1 DE 60119514D1 DE 60119514 T DE60119514 T DE 60119514T DE 60119514 T DE60119514 T DE 60119514T DE 60119514 D1 DE60119514 D1 DE 60119514D1
Authority
DE
Germany
Prior art keywords
amino
leucyl
tert
hydroxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60119514T
Other languages
English (en)
Other versions
DE60119514T2 (de
Inventor
Pascal Furet
Carlos Garcia-Echeverria
Patricia Imbach
Marc Lang
Johann Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE60119514D1 publication Critical patent/DE60119514D1/de
Application granted granted Critical
Publication of DE60119514T2 publication Critical patent/DE60119514T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60119514T 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure Expired - Fee Related DE60119514T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0012795 2000-05-25
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds
PCT/EP2001/005952 WO2001089282A2 (en) 2000-05-25 2001-05-23 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives

Publications (2)

Publication Number Publication Date
DE60119514D1 true DE60119514D1 (de) 2006-06-14
DE60119514T2 DE60119514T2 (de) 2006-10-05

Family

ID=9892401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60119514T Expired - Fee Related DE60119514T2 (de) 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure

Country Status (11)

Country Link
US (2) US20030166572A1 (de)
EP (1) EP1290012B1 (de)
JP (1) JP2003533541A (de)
AT (1) ATE325809T1 (de)
AU (1) AU2001266019A1 (de)
CA (1) CA2405871A1 (de)
DE (1) DE60119514T2 (de)
ES (1) ES2261422T3 (de)
GB (1) GB0012795D0 (de)
PT (1) PT1290012E (de)
WO (1) WO2001089282A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507484A1 (en) * 2002-11-27 2004-06-17 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
EP1865950B1 (de) 2005-04-07 2013-08-28 Centre National de la Recherche Scientifique Verbindungen zur regulierung der proteasomaktivität
WO2009106574A2 (en) * 2008-02-28 2009-09-03 Novartis Ag Combinations for treating hiv-associated pain
EP2399129B1 (de) 2009-02-20 2015-11-25 Michael P. Lisanti Verfahren zur diagnose bzw. prognose eines neoplasmas einschliesslich der bestimmung des expressionsgrads eines proteins in stromazellen neben dem neoplasma
US10085987B2 (en) 2012-01-27 2018-10-02 Thomas Jefferson University MCT protein inhibitor-related prognostic and therapeutic methods
US10022372B2 (en) 2013-04-19 2018-07-17 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
SG11202010925UA (en) * 2018-05-29 2020-12-30 Omeros Corp Masp-2 inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
EP0982317A1 (de) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalente Proteasome Inhibitore
ES2223512T3 (es) * 1999-04-27 2005-03-01 Novartis Ag Uso de derivados de acidos 2,4-diamino-3-hidroxicarboxilicos como inhibidores de la proteasoma.

Also Published As

Publication number Publication date
ATE325809T1 (de) 2006-06-15
AU2001266019A1 (en) 2001-12-03
US20060205673A1 (en) 2006-09-14
ES2261422T3 (es) 2006-11-16
WO2001089282A2 (en) 2001-11-29
US20030166572A1 (en) 2003-09-04
EP1290012B1 (de) 2006-05-10
DE60119514T2 (de) 2006-10-05
CA2405871A1 (en) 2001-11-29
PT1290012E (pt) 2006-09-29
JP2003533541A (ja) 2003-11-11
EP1290012A2 (de) 2003-03-12
GB0012795D0 (en) 2000-07-19
WO2001089282A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
ATE361287T1 (de) Neue indol-2-on derivate
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
DE60144392D1 (de) Antivirale mittel
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
MXPA04000577A (es) Derivados de dolastatina 10.
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
DE60045508D1 (de) Dalda-analoge und ihre verwendung
ATE300541T1 (de) Pyrazolopyridinderivate
TW200508207A (en) New benzimidazole derivatives
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
DE60001586D1 (de) Diphenyl-piperidin derivate
SE9804212D0 (sv) Compounds
MXPA05010020A (es) Derivados de oxamida.
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
DE60023154D1 (de) Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Ref document number: 1290012

Country of ref document: EP

R082 Change of representative

Ref document number: 1290012

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE